Artículos del autor

solaci

Day 2

FORWARD Trial: Use of Omega 3 to prevent recurring atrial fibrillation

Atrial fibrillation (AF) is a very prevalent arrhythmia and there is no known drug, device or ablation...
solaci -
Day 2

Monoclonal antibodies for the treatment of dislipidemia in patients on maximal dose statins.

Statins are first-line therapy for hypercholesterolemia. However, many patients are not able to achieve their goals despite...
solaci -
Day 2

DALCETRAPIB: Dalcetrabib for the treatment of ACS

High levels of HDL are known to exert a protective effect. In previous studies, dalcetrapib administration increased...
solaci -
SOLACI Session

CREST, ACT 1 and Other Trials

William A. Gray2013-03-09
solaci -
SOLACI Session

An interventional cardiologist`s perspective on endovascular therapy for AAA

Guering Eid-Lidt2013-03-09
solaci -
Day 1

Artic Study: Bedside Platelet Function Monitoring to Reduce Events after DES Implantation .

Given the individual variability of response to antiplatelet therapies, measuring platelet function and designing tailored therapies could...
solaci -
Day 1

CPORT-E: Comparison of percutaneous treatment cost in hospitals with and without central vascular surgery.

A total of 18,273 patients receiving angioplasty in hospitals with or without central vascular surgery were followed...
solaci -
Day 3

PRAGUE-6: off-pump versus in-pump CABG in high-risk patients

Coronary artery bypass grafting (CABG) without a cardiopulmonary bypass, (CBP), has increasingly become an alternative to the...
solaci -